Using CRISPR gene editing, a team from Children’s Hospital of Philadelphia (CHOP) and Penn Medicine have thwarted a lethal lung disease in an animal model in which a harmful mutation causes death within hours after birth.
This proof-of-concept study, published today in Science Translational Medicine, showed that in uteroediting could be a promising new approach for treating lung diseases before birth.
“The developing fetus has many innate properties that make it an attractive recipient for therapeutic gene editing,” said study co-leader William H. Peranteau, MD, an investigator at CHOP’s Center for Fetal Research, and a pediatric and fetal surgeon in CHOP’s Center for Fetal Diagnosis and Treatment. “Furthermore, the ability to cure or mitigate a disease via gene editing in mid- to late gestation before birth and the onset of irreversible pathology is very exciting. This is particularly true for diseases that affect the lungs, whose function becomes dramatically more important at the time of birth.”
The lung conditions the team is hoping to solve — congenital diseases such as surfactant protein deficiency, cystic fibrosis, and alpha-1 antitrypsin — are characterized by respiratory failure at birth or chronic lung disease with few options for therapies. About 22 percent of all pediatric hospital admissions are because of respiratory disorders, and congenital causes of respiratory diseases are often lethal, despite advances in care and a deeper understanding of their molecular causes. Because the lung is a barrier organ in direct contact with the outside environment, targeted delivery to correct defective genes is an attractive therapy.
“We wanted to know if this could work at all,” said study co-leader Edward E. Morrisey, PhD, a professor of Cardiovascular Medicine in the Perelman School of Medicine at the University of Pennsylvania. “The trick was how to direct the gene-editing machinery to target cells that line the airways of the lungs.”
The researchers showed that precisely timed in utero delivery of CRISPR gene-editing reagents to the amniotic fluid during fetal development resulted in targeted changes in the lungs of mice. They introduced the gene editors into developing mice four days before birth, which is analogous to the third trimester in humans.
The cells that showed the highest percentage of editing were alveolar epithelial cells and airway secretory cells lining lung airways. In 2018, a team led by Morrisey identified the alveolar epithelial progenitor (AEP) lineage, which is embedded in a larger population of cells called alveolar type 2 cells. These cells generate pulmonary surfactant, which reduces surface tension in the lungs and keeps them from collapsing with every breath. AEPs are a stable cell type in the lung and turn over very slowly, but replicate rapidly after injury to regenerate the lining of the alveoli and restore gas exchange.
In a second experiment, the researchers used prenatal gene editing to reduce the severity of an interstitial lung disease, surfactant protein C (SFTPC) deficiency, in a mouse model that has a common disease-causing mutation found in the human SFTPC gene. One hundred percent of untreated mice with this mutation die from respiratory failure within hours of birth. In contrast, prenatal gene editing to inactivate the mutant Sftpc gene resulted in improved lung morphology and survival of over 22 percent of the animals.
Future studies will be directed toward increasing the efficiency of the gene editing in the epithelial lining of lungs as well as evaluating different mechanisms to deliver gene editing technology to lungs. “Different gene editing techniques are also being explored that may one day be able to correct the exact mutations observed in genetic lung diseases in infants,” Morrisey said.
The Latest on: Gene editing
via Google News
The Latest on: Gene editing
- Nobel Prize for chemistry honors exquisitely precise gene-editing technique, CRISPR – a gene engineer explains how it workson October 7, 2020 at 9:14 pm
Researchers have been able to manipulate large chunks of genetic code for almost 50 years. But it is only within the past decade that they have been able to do it with exquisite precision – adding, de ...
- 2 women win Nobel Prize in chemistry for gene-editing methodon October 7, 2020 at 8:11 pm
Two scientists won the Nobel Prize in chemistry Wednesday for developing a way of editing genes that could one day cure inherited diseases. Frenchwoman Emmanuelle Charpentier and American Jennifer ...
- 2 scientists win Nobel chemistry prize for gene-editing toolon October 7, 2020 at 4:37 pm
The Nobel Prize in chemistry has been awarded to two researchers for a gene-editing tool that has revolutionized science by providing a way to alter DNA, the code of life ...
- Gene-editing tool CRISPR wins the chemistry Nobelon October 7, 2020 at 3:11 pm
A gene-editing tool developed just eight years ago that has “revolutionized the life sciences” nabbed the 2020 Nobel Prize in chemistry.
- Gene-editing CRISPR technique can help us cut emissions from farmingon October 7, 2020 at 11:57 am
There are risks to using CRISPR, but also to not embracing it, because it will be much harder to reduce greenhouse gas emissions from food production without gene editing ...
- Pioneers of revolutionary CRISPR gene editing win chemistry Nobelon October 7, 2020 at 9:34 am
Emmanuelle Charpentier and Jennifer Doudna share the award for developing the precise genome-editing technology.
- 2 women earn Chemistry Nobel Prize for gene-editing tool CRISPRon October 7, 2020 at 8:58 am
Nobel Prize in chemistry went to two women who developed a gene-editing tool called CRISPR-Cas9, which snips DNA like a pair of molecular scissors. The technique "has not ...
- Nobel Prize in chemistry awarded to two women who developed CRISPR, a revolutionary gene-editing toolon October 7, 2020 at 8:10 am
This year’s prize is about rewriting the code of life,” said . This was the first time two women jointly won a Nobel in chemistry. “I wish that this will provide a positive message, specifically, to ...
- The Nobel Prize in chemistry has gone to the two women who pioneered CRISPR gene editingon October 7, 2020 at 7:19 am
The Nobel Prize in Chemistry 2020 was awarded today to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing” called CRISPR. Genetic scissors: The Nobel ...
- Two women share Nobel chemistry prize for gene-editing discoverieson October 7, 2020 at 5:52 am
This year’s Nobel Prize in chemistry has been awarded to Emmanuelle Charpentier of France and Jennifer Doudna of the US for their pioneering work in developing the Crispr gene editing technique that ...
via Bing News